Peter Held

4.7k total citations · 1 hit paper
35 papers, 1.7k citations indexed

About

Peter Held is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Held has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Held's work include Heart Failure Treatment and Management (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Peter Held is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Peter Held collaborates with scholars based in Sweden, United States and United Kingdom. Peter Held's co-authors include Salim Yusuf, Karl Swedberg, John J.V. McMurray, Karl Swedberg, Eric L. Michelson, Bertil Olofsson, Jan Östergren, Axel F. Sigurðsson, Marc S. Sabatine and Robert F. Storey and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Peter Held

34 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

2016 249 citations Marc P. Bonaca, Deepak L. Bhatt et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Held Sweden	18	1.5k	424	277	206	147	35	1.7k
Jindřich Špinar Czechia	21	1.1k 0.7×	674 1.6×	257 0.9×	179 0.9×	138 0.9×	68	1.7k
Luc Missault Belgium	16	1.7k 1.1×	977 2.3×	144 0.5×	330 1.6×	144 1.0×	59	2.2k
Stig Persson Sweden	11	1.5k 1.0×	205 0.5×	187 0.7×	181 0.9×	43 0.3×	31	1.7k
W. Van Mieghem Belgium	15	600 0.4×	278 0.7×	163 0.6×	163 0.8×	70 0.5×	50	949
H. J. G. M. Crijns Netherlands	17	1.3k 0.9×	129 0.3×	103 0.4×	150 0.7×	72 0.5×	26	1.7k
M. L. Simoons Netherlands	17	1.1k 0.7×	430 1.0×	183 0.7×	44 0.2×	147 1.0×	44	1.4k
Juan Quiles Spain	21	1.0k 0.7×	431 1.0×	121 0.4×	164 0.8×	109 0.7×	69	1.5k
Gianna Fabbri Italy	14	931 0.6×	156 0.4×	95 0.3×	105 0.5×	49 0.3×	36	1.1k
Christine S. Zuern Germany	22	1.4k 0.9×	467 1.1×	117 0.4×	162 0.8×	171 1.2×	75	1.7k
Ján Murín Slovakia	15	782 0.5×	252 0.6×	173 0.6×	82 0.4×	49 0.3×	84	1.2k

Countries citing papers authored by Peter Held

Since Specialization

Citations

This map shows the geographic impact of Peter Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Held more than expected).

Fields of papers citing papers by Peter Held

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Held. The network helps show where Peter Held may publish in the future.

Co-authorship network of co-authors of Peter Held

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Held. A scholar is included among the top collaborators of Peter Held based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Held. Peter Held is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bansilal, Sameer, Marc P. Bonaca, Jan H. Cornel, et al.. (2018). Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease. Journal of the American College of Cardiology. 71(5). 489–496. 43 indexed citations

Bansilal, Sameer, Marc P. Bonaca, Jan H. Cornel, et al.. (2016). EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL. Journal of the American College of Cardiology. 67(13). 2146–2146. 3 indexed citations

Bonaca, Marc P., Deepak L. Bhatt, Robert F. Storey, et al.. (2016). EFFICACY AND SAFETY OF TICAGRELOR AS LONG-TERM SECONDARY PREVENTION IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION AND PERIPHERAL ARTERY DISEASE. Journal of the American College of Cardiology. 67(13). 2266–2266. 12 indexed citations

Bonaca, Marc P., Deepak L. Bhatt, Robert F. Storey, et al.. (2016). Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology. 67(23). 2719–2728. 249 indexed citations breakdown →

Bhatt, Deepak L., Marc P. Bonaca, Sameer Bansilal, et al.. (2016). Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54. Journal of the American College of Cardiology. 67(23). 2732–2740. 127 indexed citations

Bonaca, Marc P., Deepak L. Bhatt, Philippe Gabríel Steg, et al.. (2015). TCT-78 Efficacy of Long-Term Ticagrelor in Stented Patients in PEGASUS-TIMI 54. Journal of the American College of Cardiology. 66(15). B36–B36. 5 indexed citations

Bonaca, Marc P., Deepak L. Bhatt, Eugene Braunwald, et al.. (2014). Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. American Heart Journal. 167(4). 437–444.e5. 73 indexed citations

Hoerauf, Klaus, et al.. (2008). Vorhofseptumaneurysma als Ursache eines thrombembolischen Stamm- und Kleinhirninfarkts?. DMW - Deutsche Medizinische Wochenschrift. 118(34/35). 1236–1240. 1 indexed citations

Young, James B., Mark E. Dunlap, Marc A. Pfeffer, et al.. (2004). Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction. Circulation. 110(17). 2618–2626. 282 indexed citations

10.

Held, Peter, Hans Wedel, & Lars Wilhelmsen. (2003). Clinical trials: introduction. Journal of Internal Medicine. 254(2). 103–104. 3 indexed citations

11.

Yusuf, Salim, Karl Swedberg, C. B. Granger, et al.. (2003). CHARM INVESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT-VENTRICULAR EJECTION FRACTION: THE CHARM-PRESERVED TRIAL. 362. 777–781. 329 indexed citations

12.

Cairns, John A., Alfred P. Hallstrom, & Peter Held. (2001). Should all trials have a Data Safety and Monitoring Committee?. American Heart Journal. 141(1). 156–163. 14 indexed citations

13.

Schaufelberger, Maria, Göran Andersson, Bengt O. Eriksson, et al.. (1996). Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril. European Heart Journal. 17(11). 1678–1685. 37 indexed citations

14.

Teger‐Nilsson, Ann‐Catrine, et al.. (1995). 931-115 Phase I Studies on Inogatran, a New Selective Thrombin Inhibitor. Journal of the American College of Cardiology. 25(2). 117A–118A. 7 indexed citations

15.

Held, Peter. (1993). Effects of beta blockers on ventricular dysfunction after myocardial infarction: Tolerability and survival effects. The American Journal of Cardiology. 71(9). C39–C44. 25 indexed citations

16.

Yusuf, Salim, Rekha Garg, Peter Held, & Richard Gorlin. (1992). Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure. The American Journal of Cardiology. 69(18). 64–70. 50 indexed citations

17.

Sigurðsson, Axel F., et al.. (1991). Enalaprilat in acute myocardial infarction: tolerability and effects on the renin-angiotensin system. International Journal of Cardiology. 33(1). 115–124. 13 indexed citations

18.

Held, Peter & Salim Yusuf. (1989). Early Intravenous Beta-Blockade in Acute Myocardial Infarction. Cardiology. 76(2). 132–143. 20 indexed citations

19.

Held, Peter, et al.. (1989). Renin response to sympathetic stimulation in cyclosporin-treated heart-transplant patients. The American Journal of Cardiology. 63(15). 1142–1144. 6 indexed citations

20.

Held, Peter & O. Nickel. (1984). Rechnerunterstützte Auswertung von Ultraschallbildern der Schilddrüse. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 141(8). 185–191. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact